Placing COURAGE in context: Review of the recent literature on managing stable coronary artery disease

Mayo Clinic Proceedings

Volumn 83, Issue 7, 2008, Pages 799-805

  Coylewright, Megan ^a   Blumenthal, Roger S ^a   Post, Wendy ^a,b,c  

^a University School of Medicine   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGIOPLASTY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FOLLOW UP; HEART INFARCTION; HUMAN; MEDICAL LITERATURE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; REVIEW; UNITED STATES;

EID: 46749159233     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.7.799     Document Type: Review

References (34)

1. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356(23):2388-2398.
2. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol. 2004;44(3):E1-E211.
3. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-STsegment elevation myocardial infarction - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol. 2002;40(7):1366-1374.
4. Hochman JS, Lamas GA, Buller CE, et al, Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006 Dec 7;355(23):2395-2407. Epub 2006 Nov 14.
5. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation. 2003;107(1):149-158.
6. Lin GA, Dudley RA, Redberg RE. Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease. Arch Intern Med. 2007;167(15):1604-1609.
7. Levit K, Ryan K, Elixhauser A, Stanges E, Kassed C, Coffey R. HCUP Facts and Figures: Statistics on Hospital-based Care in the United States, 2005. Agency for Healthcare Research and Quality Web site. http://www.hcup-us.ahrq. gov/reports/annualreport/HAR_2005.pdf. Accessed June 2, 2008.
8. Feldman DN, Gade CL, Slotwiner AJ, et al. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry). Am J Cardiol. 2006 Nov 15;98(10):1334-1339. Epub 2006 Sep 28.
9. Wharton TP Jr, Umans VA, Peels HO. PCI for stable coronary disease [letter]. N Engl J Med. 2007; 357(4):415.
10. Boden WE, O'Rourke RA, Teo KK, et al, COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007 Apr 12;356(15):1503-1516. Epub 2007 Mar 26.
11. Diamond GA, Kaul S. COURAGE under fire: on the management of stable coronary disease. J Am Coll Cardiol. 2007 Oct 16;50(16):1604-1609. Epub 2007 Sep 17.
12. Kereiakes DJ, Teirstein PS, Sarembock IJ, et al. The truth and consequences of the COURAGE trial. J Am Coll Cardiol. 2007 Oct 16;50(16):1598-1603. Epub 2007 Sep 17.
13. Yusuf S, Fallen E, Harrington RA, Guyton RA. Clinical decisions: management of stable coronary disease. N Engl J Med. 2007;357(17):1762- 1766.
14. Blumenthal RS, Cohn G, Schulman SP. Medical therapy versus coronary angioplasty in stable coronary artery disease: a critical review of the literature [published correction appears in J Am Coll Cardiol. 2001;37(1):339]. J Am Coll Cardiol. 2000;36(3):668-673.
15. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation. 2005 Jun 7;111(22):2906-2912. Epub 2005 May 31.
16. Pitt B, Waters D, Brown WV, et al, Atorvastatin versus Revascularization Treatment Investigators. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med. 1999;341(2):70-76.
17. RITA-2 Trial Participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet. 1997;350(9076):461-468.
18. Henderson RA, Pocock SJ, Clayton TC, et al, Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol. 2003;42(7):1161-1170.
19. TIME investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. Lancet. 2001;358(9286):951-957.
20. Pfisterer M, TIME Investigators. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation. 2004 Sep 7;110(10):1213-1218. Epub 2004 Aug 30.
21. Hueb W, Soares PR, Gersh BJ, et al. The Medicine, Angioplasty, or Surgery Study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol. 2004;43(10):1743-1751.
22. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS-II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115(9):1082-1089.
23. Erne P, Schoenenberger AW, Burckhardt D, et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA. 2007;297(18):1985-1991.
24. Ryan TJ, Bauman WB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1993;88(6):2987-3007.
25. Boden WE, O'Rourke RA, Teo KK, et al, COURAGE Trial Coprincipal Investigators and Study Coordinators. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial: Veterans Affairs Cooperative Studies Program no. 424. Am Heart J. 2006;151(6):1173-1179.
26. Steinberg BA, Steg PG, Bhatt DL, Fonarow GC, Zeymer U, Cannon CP, REACH Registry Investigators. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry). Am J Cardiol. 2007 May 1;99(9):1212-1215. Epub 2007 Mar 16.
27. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007 Mar 8; 356(10):1030-1039. Epub 2007 Feb 12.
28. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002;106(14):1883-1892.
29. Blumenthal RS, Bairey Merz CN, Bittner V, Gluckman TJ. Task force 10: training in preventive cardiovascular medicine. J Am Coll Cardiol. 2008;51(3):393-398.
30. Sangiorgi G, Rumberger JA, Severson A, et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using non-decalcifying methodology. J Am Coll Cardiol. 1998;31(1):126-133.
31. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation. 1995;92(8):2157-2162.
32. Levine GN, Keaney JF Jr, Vita JA. Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med. 1995;332(8):512-521.
33. Smith SC Jr. Evidence-based medicine: making the grade: miles to go before we sleep [editorial]. Circulation. 2006;113(2):178-179.
34. Gluckman TJ, Sachdev M, Schulman SP, Blumenthal RS. A simplified approach to the management of non-ST-segment elevation acute coronary syndromes [published correction appears in JAMA. 2005;293(14):1728]. JAMA. 2005;293(3):349-357.